Table 1.
CON (n=12) |
HMO (n=12) |
BMOS (n=12) |
BMOS+HMO (n=10) |
Statistics | |
---|---|---|---|---|---|
PBMC | Percent of Cells* | ||||
T-helper cells | 49.4 ± 2.1 a | 53.7 ± 2.5 a | 49.9 ± 2.0 a | 42.7 ± 1.7 b | BMOS*HMO: p=0.007 |
Cytotoxic T-cells | 11.9 ± 1.2 | 12.0 ± 1.1 | 12.1 ± 1.1 | 11.9 ± 1.5 | N.S. |
Double positive T-cells | 5.3 ± 0.6 | 6.2 ± 0.6 | 5.7 ± 0.9 | 5.0 ± 0.5 | N.S. |
Natural Killer cells | 12.5 ± 2.5 | 10.1 ± 1.9 | 11.0 ± 2.5 | 11.5 ± 3.0 | N.S. |
B-cells | 14.0 ± 5.6 | 12.3 ± 2.3 | 12.2 ± 2.7 | 11.9 ± 2.4 | N.S. |
MLN | |||||
T-helper cells | 72.6 ± 1.1 | 72.5 ± 1.0 | 74.9 ± 1.6 | 73.6 ± 2.6 | N.S. |
Cytotoxic T-cells | 11.4 ± 0.8 | 12.8 ± 0.9 | 11.5 ± 0.9 | 11.0 ± 1.7 | N.S. |
Double positive T-cells | 8.2 ± 1.1 | 7.3 ± 0.9 | 7.3 ± 0.8 | 8.7 ± 1.0 | N.S. |
Natural Killer cells | 1.4 ± 0.2 | 1.6 ± 0.1 | 1.4 ± 0.1 | 1.4 ± 0.1 | N.S. |
B-cells | 53 ± 3.7 | 61 ± 5.4 | 54 ± 5.2 | 57 ± 5.1 | N.S. |
Spleen | |||||
T-helper cells | 46.9 ± 2.5 | 47.7 ± 3.3 | 47.4 ± 1.3 | 41.9 ± 3.1 | N.S. |
Cytotoxic T-cells | 9.9 ± 1.1 | 10.1 ± 1.1 | 10.7 ± 1.4 | 11.7 ± 1.3 | N.S. |
Double positive T-cells | 3.4 ± 0.3 | 4.1 ± 0.6 | 4.6 ± 0.8 | 4.0 ± 0.5 | N.S. |
Natural Killer cells | 5.6 ± 1.5 | 4.8 ± 1.2 | 4.6 ± 0.8 | 4.2 ± 0.7 | N.S. |
B-cells | 41.4 ± 5.0 | 42.0 ± 4.5 | 44.4 ± 4.7 | 40.8 ± 7.7 | N.S. |
Immune cell population were characterized as: B-cells, MHCII+CD21+; Natural Killer cells, CD3-CD4+CD8; T-helper cells, CD3+CD4+CD8+, Cytotoxic T-cells, CD3+CD4-CD8+; Double positive T-cells, CD3+CD4+CD8.
*T-cell numbers are presented as % of CD3+ cells; B-cell numbers represent % of total cell count.
Data are presented as mean % ± SEM.
Different letters represent statistical differences at p<0.05; N.S. Not statistically significant.
MLN, mesenteric lymph nodes; PBMC, peripheral blood mononuclear cells; UNST, unstimulated.